Therapeutic and Safety Evaluation of Enhydra fluctuans Lour. and Ipomoea aquatica Forssk. as Acetylcholinesterase, Butyrylcholinesterase, β‐Secretase, and CytochromeP450 Inhibitors Using In Vitro and UPLC–QTOF–MS‐Based Molecular Docking and Dynamic Simulation Study
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202501969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Bhaskar Das und 6 weiteren Autor:innen. Beteiligte Einrichtung: BRIC-Institute of Bioresources and Sustainable Development (BRIC-IBSD), Department of Biotechnology, Government of India, Meghalaya Center, Shillong,…. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Cholinesterase Inhibitors, Ipomoea, Plant Extracts. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Considering the multi‐targeted drug approach, Enhydra fluctuans and Ipomoea aquatica were comprehensively investigated for their acetylcholinesterase, butyrylcholinesterase, and β‐secretase enzyme inhibitory potential, which are linked to Alzheimer's disease. The results showed that I. aquatica produced more prominent anti‐cholinesterase potential compared to E. fluctuans . But E. fluctuans showed more potent BACE1 inhibitory potential compared to I. aquatica . For the safety study, the extracts were tested for heavy metal content estimation, CYP450 isozyme inhibitory potential, and cytotoxicity in human hepatocellular carcinoma cells. Antioxidant capacity, total phenolics, and total flavonoids were significantly correlated with the anti‐cholinesterase activity, where I. aquatica showed more protuberant potential compared to E. fluctuans . The UPLC–QTOF–MS analysis tentatively identified phytometabolites from the phenylethanoid glycosides and chlorogenic acids class in both the extracts. Further, in silico toxicity prediction, molecular docking, and dynamic simulation studies provided additional evidence on the safety profile and interaction potential of phytometabolites with AChE, BChE, and BACE1 enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BRIC-Institute of Bioresources and Sustainable Development (BRIC-IBSD), Department of Biotechnology, Government of India, Meghalaya Center, Shillong, Meghalaya, India.
- Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.
- BRIC-IBSD, Mizoram Center, Aizawl, Mizoram, India.
- Department of Chemistry, University of Pretoria, Pretoria, South Africa.
- Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
ORCID-Profile: Bhaskar Das, Pulok Kumar Mukherjee
Zitieren
APA
Das, B., Mukherjee, P. K., Thorat, S. S., Maharaj, V., Bodede, O., Khorommbi, N. K., & Matsabisa, M. G. (2026). Therapeutic and Safety Evaluation of Enhydra fluctuans Lour. and Ipomoea aquatica Forssk. as Acetylcholinesterase, Butyrylcholinesterase, β‐Secretase, and CytochromeP450 Inhibitors Using In Vitro and UPLC–QTOF–MS‐Based Molecular Docking and Dynamic Simulation Study. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501969
Vancouver
Das B, Mukherjee PK, Thorat SS, Maharaj V, Bodede O, Khorommbi NK, et al. Therapeutic and Safety Evaluation of Enhydra fluctuans Lour. and Ipomoea aquatica Forssk. as Acetylcholinesterase, Butyrylcholinesterase, β‐Secretase, and CytochromeP450 Inhibitors Using In Vitro and UPLC–QTOF–MS‐Based Molecular Docking and Dynamic Simulation Study. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202501969
BibTeX
@article{Das2026,
author = {Das, Bhaskar and Mukherjee, Pulok Kumar and Thorat, Sunil S and Maharaj, Vinesh and Bodede, Olusola and Khorommbi, Ndivhuwo Kevin and Matsabisa, Motlalepula G},
title = {Therapeutic and Safety Evaluation of Enhydra fluctuans Lour. and Ipomoea aquatica Forssk. as Acetylcholinesterase, Butyrylcholinesterase, β‐Secretase, and CytochromeP450 Inhibitors Using In Vitro and UPLC–QTOF–MS‐Based Molecular Docking and Dynamic Simulation Study},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202501969}
}
EUVIMED